In the second quarter of 2008, revenues for IBO’s Laboratory Sales Index grew 13.7% to $4,624 million, compared to growth of 13.3% in second quarter of 2007. Operating profit climbed 20.4% to $747 million, and operating margin climbed 90 basis points to 16.2% of sales. While several companies, such as Affymetrix, Harvard Bioscience and Tecan, […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.